Welcome to our dedicated page for Nukkleus SEC filings (Ticker: NUKKW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Nukkleus Inc. warrants page for symbol NUKKW provides access to the company’s SEC filings related to its common stock and listed warrants on The Nasdaq Stock Market LLC. These filings, which include Forms 8-K and registration statements such as the S-1/A, offer detailed information about Nukkleus’ capital structure, financing arrangements, warrant terms and strategic transactions across financial technology, digital assets, and defense and aerospace initiatives.
In its S-1/A registration statement, Nukkleus describes its evolution into a financial technology company following a business combination, outlining its role in blockchain-enabled technology solutions and transactions technology. The registration statement also covers resale registration for common stock and warrants issued in private placements, including pre-funded warrants and common warrants subject to beneficial ownership limitations. Investors can use these documents to understand how many shares and warrants are registered for resale, the terms of those securities, and the company’s status as an emerging growth company.
Recent Form 8-K filings provide further insight into Nukkleus’ financing and strategic activities. One 8-K details a private placement of Series A Convertible Preferred Stock and common stock purchase warrants, including the stated value of the preferred shares, initial conversion price, anti-dilution adjustments, beneficial ownership blockers and liquidation preferences. Another 8-K describes an equity line of credit agreement allowing the company to sell common shares to an investor up to a defined total commitment, subject to an exchange cap and beneficial ownership limits, with pricing based on discounts to recent trading prices. These filings also explain intended uses of proceeds, such as working capital and general corporate purposes.
Other 8-Ks document material agreements that affect Nukkleus’ business profile, such as the Exclusive Distribution Agreement with Blade Ranger Ltd. for a defense and homeland security drone payload, the Joint Venture Agreement with Mandragola Ltd. and Nukk Picolo Ltd. for aviation-related manufacturing zones and a NATO-compliant logistics hub, and the Stock Purchase Agreement to acquire Tiltan Software Engineering Ltd., which specializes in AI software for defense and aerospace. Additional filings describe a warrant agreement with Synthetic Darwin LLC for Darwin tokens and amendments to a Securities Purchase Agreement and Call Option involving Star 26 Capital Inc.
Through Stock Titan, users can view these filings in one place and use AI-powered summaries to quickly understand key terms, such as conversion mechanics of preferred stock, exercise terms of warrants (including NUKKW), conditions in joint venture and acquisition agreements, and Nasdaq listing notices. The platform’s tools help interpret complex documents like 10-Ks, 10-Qs, S-1/A registration statements and 8-K current reports by highlighting important sections on capital structure, risk factors, financing covenants and strategic commitments.
Item 8.01 – Subsidiary enters administration; DRFQ divested. On 29-Jul-25, UK subsidiary Match Financial Ltd. was placed into administration under the Insolvency Act 1986. Court-appointed administrators immediately executed a pre-pack sale of Match Financial’s entire holding in Digital RFQ Ltd. to newly formed Match Financial Holdings Ltd., owned by director Jamal Khurshid, for nominal consideration of £102,000.
The sale removes DRFQ from Nukkleus’s consolidation. Management states Match Financial contributed “negligible” revenue and assets, so it does not expect a material adverse impact on the group’s financial position or operations.
Strategic update – Star 26 Capital acquisition. The Company continues to seek shareholder approval for the December 2024 Securities Purchase Agreement and Call Option to acquire a controlling 51 % stake in Star 26 Capital Inc., which owns Israeli generator supplier Rimon and would advance Nukkleus’s defence-sector strategy.